Search alternatives:
small decrease » small increased (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
small decrease » small increased (Expand Search)
large decrease » larger decrease (Expand Search), marked decrease (Expand Search), large increases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a large » _ large (Expand Search)
-
1
-
2
-
3
-
4
-
5
Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc
Published 2025“…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Data Sheet 1_Patient engagement in radiation oncology: a large retrospective study of survey response dynamics.docx
Published 2025“…</p>Methods<p>This retrospective study analyzed data from radiation oncology patients at a large multi-site single-institution center from May 2021 to January 2024. …”
-
18
-
19
-
20